Physician
NPI deactivated
Associated Pain Specialists, PC
Associated Pain Specialists, PC was paid $259K by Medicaid between Jan 2018 and Aug 2023, across 23 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 67% of everything it billed.
33Billing provider infoASSOCIATED PAIN SPECIALISTS, PC
GRAY, TN 37615
GRAY, TN 37615
33aNPI1760803324assigned 12/30/2013
33bProvider typePain Medicine Physician
28Total paid$259K
24GClaims8,965
24DCodes billed23
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Pain Medicine Physician providers in Tennessee
Rank by total paid#4 of 13
Median peer was paid$31K
This provider vs. median8.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,054 | $188K | |
| 2019 | 1,076 | $49K | |
| 2020 | 155 | $5K | |
| 2022 | 36 | $3K | |
| 2023 | 644 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 67% | 4,883 | 4,104 | $173K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.4% | 1,111 | 997 | $22K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.3% | 443 | 393 | $11K |
| 93923 | 2.7% | 226 | 81 | $7K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 2.6% | 106 | 96 | $7K |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 2.4% | 96 | 38 | $6K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.4% | 146 | 120 | $6K |
| 80305 | 2.3% | 927 | 855 | $6K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.9% | 72 | 66 | $5K |
| L0637 | Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | 1.3% | 15 | 15 | $3K |
| 96132 | <1% | 104 | 101 | $2K | |
| 95924 | <1% | 75 | 50 | $2K |
11 more codes
| 96130 | <1% | 105 | $2K | |
| 64493 | <1% | 27 | $2K | |
| 20552 | <1% | 50 | $839.29 | |
| 64494 | <1% | 27 | $710.84 | |
| 96138 | <1% | 103 | $628.46 | |
| 81025 | <1% | 169 | $622.27 | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 104 | $489.61 |
| 93040 | <1% | 112 | $405.77 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $263.34 |
| 82962 | <1% | 35 | $39.98 | |
| 36416 | <1% | 17 | $11.48 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialO'DELL, ROBERT (SECRETARY)